Issue navigation
Volume 28, Issue 8, August 2022
Leading Off
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD
Annick Moens and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1135–1142, https://doi.org/10.1093/ibd/izab257
Mechanoscopy: A Novel Device and Procedure for in vivo Detection of Chronic Colitis in Mice
Shijie He and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1143–1150, https://doi.org/10.1093/ibd/izac046
Clinical Research
Alcohol Consumption is Associated With An Increased Risk of Microscopic Colitis: Results From 2 Prospective US Cohort Studies
Blake Niccum and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1151–1159, https://doi.org/10.1093/ibd/izab220
Probability of Stoma in Incident Patients With Crohn’s Disease in Sweden 2003-2019: A Population-based Study
Åsa H Everhov and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1160–1168, https://doi.org/10.1093/ibd/izab245
Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease
Kate E Lee and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1169–1176, https://doi.org/10.1093/ibd/izab246
Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review
Natalie Yu and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1177–1188, https://doi.org/10.1093/ibd/izab247
IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease
Leigh Anne Shafer and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1189–1197, https://doi.org/10.1093/ibd/izab248
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID
Catherine Reenaers and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1198–1206, https://doi.org/10.1093/ibd/izab249
Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn’s Disease
Xavier Roblin and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1207–1218, https://doi.org/10.1093/ibd/izab253
Basic Science Research
Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro
Adam Blaisdell and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1219–1228, https://doi.org/10.1093/ibd/izac056
Divergent Adaptations in Autonomic Nerve Activity and Neuroimmune Signaling Associated With the Severity of Inflammation in Chronic Colitis
Rhian Stavely and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1229–1243, https://doi.org/10.1093/ibd/izac060
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease
Chiara Tortora and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1244–1253, https://doi.org/10.1093/ibd/izac073
Clinical Reviews
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
Nurulamin M Noor and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1254–1264, https://doi.org/10.1093/ibd/izab228
COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Kartikeya Tripathi and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1265–1279, https://doi.org/10.1093/ibd/izab236
Basic Science Review
Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease
Tanmoy Rana
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1280–1288, https://doi.org/10.1093/ibd/izac017
Clinical Brief Reports
High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease
James D Lewis and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1289–1292, https://doi.org/10.1093/ibd/izab347
Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials
Rocio Sedano and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1293–1295, https://doi.org/10.1093/ibd/izab362
Invited Commentary
Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases
Stephen J Bickston and Michael V Patrone
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1296–1297, https://doi.org/10.1093/ibd/izac086
Case Reports
Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis
Ami Kawamoto and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1298–1299, https://doi.org/10.1093/ibd/izac111
Letters to the Editor
A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination
Yasuhiro Masuta and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages e110–e111, https://doi.org/10.1093/ibd/izac031
Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence
Rujittika Mungmunpuntipantip and Viroj Wiwanitkit
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Page e112, https://doi.org/10.1093/ibd/izac080
Reply to Response to “‘A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination’” by Mungmunpuntipantip and Wiwanitkiton
Yasuhiro Masuta and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Page e113, https://doi.org/10.1093/ibd/izac081
Hypertensive Emergency After Initiating Ozanimod: A Case Report
David K Choi and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages e114–e115, https://doi.org/10.1093/ibd/izac032
Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease
Amit Yadav and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages e116–e117, https://doi.org/10.1093/ibd/izac033
Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver Transplant
Adam R Peterson and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages e118–e119, https://doi.org/10.1093/ibd/izac034
Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients
Josie Libertucci and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Page e120, https://doi.org/10.1093/ibd/izac041
Reply to “Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients”
Maya Olaisen and Reidar Fossmark
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Page e121, https://doi.org/10.1093/ibd/izac047
Positive Gluten Sensitivity Serologies and the Impact of Gluten-free Diet in Patients With IBD
Maria M Dahar and others
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages e122–e123, https://doi.org/10.1093/ibd/izac045
Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
Fernando Tavarela Veloso
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Page e124, https://doi.org/10.1093/ibd/izac042
Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub
Badar Hasan and Asad Ur Rahman
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Page e125, https://doi.org/10.1093/ibd/izac057
Advertisement
Advertisement